Clinical evaluation of sivelestat for acute lung injury/acute respiratory distress syndrome following surgery for abdominal sepsis

Drug Design, Development and Therapy

Volumn 6, Issue , 2012, Pages 273-278

  Tsuboko, Yoshiaki ^a   Takeda, Shinhiro ^a,b   Mii, Seiji ^a   Nakazato, Keiko ^a   Tanaka, Keiji ^b   Uchida, Eiji ^a   Sakamoto, Atsuhiro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

Author keywords

Abdominal sepsis; Acute lung injury; Acute respiratory distress syndrome; Sivelestat

Indexed keywords

INOTROPIC AGENT; NORADRENALIN; SIVELESTAT; VASOPRESSIN;

ABDOMINAL SURGERY; ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEMOPERFUSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; OXYGENATION; POSTOPERATIVE PERIOD; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SEPSIS; THROMBOCYTOPENIA;

EID: 84872287921     PISSN: 11778881     EISSN: None     Source Type: Journal    
DOI: 10.2147/DDDT.S36436     Document Type: Article

References (28)

1. Abraham E, Matthay MA, Dinarello CA et al. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med. 2000; 28(1):232-235.
2. Spragg RG, Lewis JF, Walmrath HD et al. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med. 2004;351(9):884-892.
3. The ARDS Clinical Trials Network. Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome. Crit Care Med. 2002;30(1):1-6.
4. The ARDS Network. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2000;283(15):1995-2002.
5. Takeda S, Ishizaka A, Fujino Y, et al. Time to change diagnostic criteria of ARDS: towards the disease entity-based subgrouping. Pulm Pharmacol Ther. 2005;18(2):115-119.
6. Tamakuma S, Ogawa M, Aikawa N, et al. Relationship between neutrophil elastase and acute lung injury in humans. Pulm Pharmacol Ther. 2004;17(5):271-279.
7. Zeiher BG, Artigas A, Vincent JL, et al. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med. 2004; 32(8):1695-1702.
8. Bersten AD, Edibam C, Hunt T, Moran J. Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian states. Am J Respir Crit Care Med. 2002;165(4): 443-448.
9. McGuire WW, Spragg RG, Cohen AB, Cochrane CG. Studies on the pathogenesis of the adult respiratory distress syndrome. J Clin Invest. 1982;69(3):543-553.
10. Guice KS, Oldham KT, Johnson KJ, Kunkel RG, Morganroth ML, Ward PA. Pancreatitis-induced acute lung injury. An ARDS model. Ann Surg. 1988;208(1):71-77.
11. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 Pt 1):818-824.
12. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644-1655.
13. Marshall JC, Cook DJ, Christou N V, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23(10):1638-1652.
14. THE ARDS Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342(18):1301-1308.
15. Zeiher BG, Matsuoka S, Kawabata K, Repine JE. Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics. Crit Care Med. 2002;30(Suppl 5): S281-S287.
16. Iwata K, Doi A, Ohji G, et al. Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis. Intern Med. 2010;49(22):2423-2432.
17. Endo S, Sato N, Yaegashi Y, et al. Sivelestat sodium hydrate improves septic acute lung injury by reducing alveolar dysfunction. Res Commun Mol Pathol Pharmacol. 2006;119(1/6):53-65.
18. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1334-1349.
19. Lin X, Yang H, Sakuragi T, et al. Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung infammation and injury and improves survival in sepsis. Am J Physiol Lung Cell Mol Physiol. 2005;289(4):583-590.
20. Kitagawa Y, Van Eeden SF, Redenbach DM, et al. Effect of mechanical deformation on structure and function of polymorphonuclear leukocytes. J Appl Physiol. 1997;82(5):1397-1405.
21. Razavi HM, Wang le F, Weicker S, et al. Pulmonary neutrophil infltration in murine sepsis: role of inducible nitric oxide synthase. Am J Respir Crit Care Med. 2004;170(3):227-233.
22. Iba T, Kidokoro A, Fukunaga M, Takuhiro K, Yoshikawa S, Sugimotoa K. Pretreatment of sivelestat sodium hydrate improves the lung microcirculation and alveolar damage in lipopolysaccharide- induced acute lung infammation in hamsters. Shock. 2006;26(1): 95-98.
23. Nishina K, Mikawa K, Takao Y, Maekawa N, Shiga M, Obara H. ONO-5046, an elastase inhibitor, attenuates endotoxin-induced acute lung injury in rabbits. Anesth Analg. 1997;84(5):1097-1103.
24. Ono S, Tsujimoto H, Hiraki S, et al. Effects of neutrophil elastase inhibitor on progression of acute lung injury following esophagectomy. World J Surg. 2007;31(10):1996-2001.
25. Donnelly SC, Strieter RM, Kunkel SL, et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet. 1993;341(8846):643-647.
26. Akamoto S, Okano K, Sano T, et al. Neutrophil elastase inhibitor (sivelestat) preserves antitumor immunity and reduces the inflammatory mediators associated with major surgery. Surg Today. 2007;37(5): 359-365.
27. Ono S, Aosasa S, Mochizuki H. Effects of a protease inhibitor on reduction of surgical stress in esophagectomy. Am J Surg. 1999;177(1): 78-82.
28. Schulze S, Sommer P, Bigler D, et al. Effect of combined prednisolone, epidural analgesia, and indomethacin on the systemic response after colonic surgery. Arch Surg. 1992;127(3):325-331.